Dupilumab: a novel treatment for asthma

by Vatrella A, Fabozzi I, Calabrese C, Maselli R, Pelaia G
Published 2014-09-01

Benralizumab in the treatment of severe asthma: design, development and potential place in therapy

by Pelaia C, Vatrella A, Bruni A, Terracciano R, Pelaia G
Published 2018-03-01

Targeted therapy in severe asthma today: focus on immunoglobulin E

by Pelaia G, Canonica GW, Matucci A, Paolini R, Triggiani M, Paggiaro P
Published 2017-06-01

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

by Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G
Published 2017-10-01

Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies

by Pelaia C, Vatrella A, Gallelli L, Lombardo N, Sciacqua A, Savino R, Pelaia G
Published 2021-03-01

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

by Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Lombardo N, Maselli R
Published 2015-10-01

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis

by Pelaia C, Lombardo N, Busceti MT, Piazzetta G, Crimi C, Calabrese C, Vatrella A, Pelaia G
Published 2021-09-01

Update on optimal use of omalizumab in management of asthma

by Pelaia G, Gallelli L, Renda T, Romeo P, Busceti MT, Grembiale RD, Maselli R, Marsico SA, Vatrella A
Published 2011-06-01

Role of biologics in severe eosinophilic asthma – focus on reslizumab

by Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R
Published 2016-07-01

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series

by Menzella F, Bonavia M, Bonini M, D'Amato M, Lombardo S, Murgia N, Patella V, Triggiani M, Pelaia G
Published 2021-02-01

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review

by Rogliani P, Calzetta L, Braido F, Cazzola M, Clini E, Pelaia G, Rossi A, Scichilone N, Di Marco F
Published 2018-10-01

Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach

by Gallelli L, Falcone D, Cannataro R, Perri M, Serra R, Pelaia G, Maselli R, Savino R, Spaziano G, D’Agostino B
Published 2017-01-01

Early management of COPD: where are we now and where do we go from here? A Delphi consensus project

by Di Marco F, Balbo P, de Blasio F, Cardaci V, Crimi N, Girbino G, Pelaia G, Pirina P, Roversi P, Santus P, Scichilone N, Vatrella A, Pasqualetti P, Carone M
Published 2019-02-01

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

by Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta Jnr D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N
Published 2021-02-01